Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study.
about
Cellular immune responses against hepatitis C virus: the evidence base 2002Response Prediction and Treatment Tailoring for Chronic Hepatitis C Virus Genotype 1 InfectionBoceprevir for untreated chronic HCV genotype 1 infectionBenefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapyRibavirin improves early responses to peginterferon through improved interferon signalingMonitoring of viral levels during therapy of hepatitis C.Recent developments in target identification against hepatitis C virus.Hepatitis C Viral Kinetics in Special PopulationsImproved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders.Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle.Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection.Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response.Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load.Hepatitis C treatment response kinetics and impact of baseline predictors.Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.Viral kinetics of hepatitis C: new insights and remaining limitations.First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline.Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection.Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.
P2860
Q27480725-0BFFAC9B-4917-4886-B7AB-C7BDF2F6B263Q27481003-5FBE0918-3962-4405-9061-AA7EC481536FQ29620617-3D802F94-FD60-4C86-84ED-AAF968763C89Q33592250-F6154293-E160-4D55-AC5F-CC93DB0351E7Q33987120-7355D07E-41E1-4171-A325-8D4A91334FCFQ34984089-127D849F-9F38-4B70-A5FF-50EF7202D026Q35842500-7A3FE08A-57C8-46A0-A071-49B9A9DD6D53Q37060801-9A4BA874-1CF6-43BA-A00F-353B2BF249D1Q41392572-017139BE-8436-4F1E-B409-CCA2D58FAB06Q42938347-BC5CA831-5DB0-42E4-B790-A67963DCF931Q42978531-251A9D2D-BA08-474B-AF76-0C40B6BE6CFDQ42988882-709FDC95-A42A-4ABB-81A5-4B9DE7B79F1DQ42990906-B9E0CBE3-EC95-4EF8-87CB-A99184549977Q42994528-511511E3-6017-4EBA-A8B9-71C5647E6DC3Q42995634-220831CD-CE5A-4FFC-8D2A-6078F5A1893DQ42997280-F16F1EFB-45DB-4D92-B83E-0A61C9D00ABEQ42997881-34854064-3493-4149-B1A8-06865746A569Q43037227-EE3BC89D-79F0-4763-A98D-790F6F7EF84BQ43039947-CAC7EF33-1883-4508-BEAC-88D6838B8850Q43039959-91FAC26C-176B-4E8C-8A77-37A62A736FDDQ43040745-49290672-A472-4632-8EEF-55A3200B3B38Q43042183-BAEB0FBE-27DA-44CA-9011-1401BCEFD918Q43047387-846123E3-8813-4172-8E49-11AAD6E900FAQ46915103-A3F85801-C95D-448E-A16D-4702EE35F0D9
P2860
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Primary interferon resistance ...... is C infection: a pilot study.
@en
Primary interferon resistance ...... is C infection: a pilot study.
@nl
type
label
Primary interferon resistance ...... is C infection: a pilot study.
@en
Primary interferon resistance ...... is C infection: a pilot study.
@nl
prefLabel
Primary interferon resistance ...... is C infection: a pilot study.
@en
Primary interferon resistance ...... is C infection: a pilot study.
@nl
P2093
P1433
P1476
Primary interferon resistance ...... is C infection: a pilot study.
@en
P2093
M Gschwantler
P Steindl-Munda
T Watkins-Riedel
P304
P356
10.1016/S0140-6736(01)06356-5
P407
P577
2001-10-01T00:00:00Z